Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 26

Sort by

Sort Order Select

Journal Articles

The Fuvid Study: Functional Characterization of Children with Pulmonary Embolism in a Prospective Multicenter Cohort Study

Blood (2024) 144 (Supplement 1): 5555.

https://doi.org/10.1182/blood-2024-202646

Published: 2024

Journal Articles

Real-World Patterns of Additional Factor Treatment Use Among Hemophilia a Patients on Regular Prophylaxis in the United States: Results from the Picnichealth Database

Jonathan C. Roberts, Angela C Weyand, Mark T Reding, Nana Kragh, Nicole Tsao, Emily Cibelli, Gillian Hanson, Duygu Bozkaya, Anne-Laure Tardy

Blood (2024) 144 (Supplement 1): 3967.

https://doi.org/10.1182/blood-2024-204580

Published: 2024

Journal Articles

Changing the Serum Ferritin Lower Limit of Normal to a Clinical Decision Limit: An Acceptability Survey

Zoe Phillips, Grace Tang, Rowan Thillaye-Kerr, Michael Fralick, Angela C Weyand, Mark A. Crowther, Rita Selby, Michelle Sholzberg

Blood (2024) 144 (Supplement 1): 7561.

https://doi.org/10.1182/blood-2024-206197

Published: 2024

Journal Articles

Diagnosis and Disease Burden of Von Willebrand Disease in a Large US Population Based-Dataset

Michelle Sholzberg, Angela C Weyand, Jacob S Lai, Benjamin Kim, Gary Patou, Nicole M. Engel-Nitz, Qiana Amos, Robert F. Sidonio, Jr.

Blood (2024) 144 (Supplement 1): 3980.

https://doi.org/10.1182/blood-2024-206631

Published: 2024

Journal Articles

Disparities in Real-World Treatment Patterns Among Patients with Von Willebrand Disease in a Large US Population-Based Dataset

Angela C Weyand, Michelle Sholzberg, Jacob S Lai, Benjamin Kim, Adam Rosenthal, Scott M Robertson, Gary Patou, Robert F. Sidonio, Jr.

Blood (2024) 144 (Supplement 1): 3978.

https://doi.org/10.1182/blood-2024-206567

Published: 2024

Journal Articles

Analysis of the Hematology Health Equity Literature: Trends By Topic and Disparity, across Journals, and over Time

James Troyer, Bonnie Lu, Kathryn Krause, Melanie Aviles, Sherraine Della-Moretta, Dre'Von Dobson, Kaveh Farrokhi, Zainul S. Hasanali, Ajibike Lapite, Pallavi Pillai, Cristian Taborda, Lynda Villagomez, Phuong T Vo, Ruth Wang'ondu, Jennifer C. Yui, Angela C Weyand, Warren B. Fingrut

Blood (2024) 144 (Supplement 1): 5207.

https://doi.org/10.1182/blood-2024-206364

Published: 2024

Journal Articles

Continuous Prophylaxis with Recombinant Von Willebrand Factor in People with Clinically Severe Congenital Types 1 and 2 Von Willebrand Disease in a Real-World Setting: Interim Analysis of Athn 9, a Natural History Study for People with Severe VWD

Robert F Sidonio, Jr., Angela C Weyand, Tammuella Chrisentery-Singleton, Martin Chandler, Carol Fedor, Priscilla Driscoll-Shempp, Michelle Kirby, Jorge Caicedo

Blood (2024) 144 (Supplement 1): 2594.

https://doi.org/10.1182/blood-2024-200261

Published: 2024

Journal Articles

Clinical Outcomes over 3 Years of Once-Weekly Efanesoctocog Alfa Treatment in Adults and Adolescents with Severe Hemophilia A: Second Interim Analysis from the Phase 3 XTEND-ed Long-Term Extension Study

Robert Klamroth, Stephanie P'ng, Sophie Susen, Davide Matino, Pratima Chowdary, Angela C Weyand, Toshko Lissitchkov, Young-Shil Park, María Teresa Alvarez-Román, Liqi Feng, Helena Palmborg, Jennifer Dumont, Elena Santagostino, Lara Mamikonian, Keiji Nogami

Blood (2024) 144 (Supplement 1): 717.

https://doi.org/10.1182/blood-2024-204533

Published: 2024

Journal Articles

Evaluation of Heavy Menstrual Bleeding in Adolescents within the Primary Care Setting

Asavari Rajpurkar, Angela C Weyand

Blood (2024) 144 (Supplement 1): 5021.

https://doi.org/10.1182/blood-2024-211422

Published: 2024

Journal Articles

Evaluating Sex-Based Hemoglobin Reference Intervals Using Strict Definitions of Health

Lauren E. Merz, Alexander Chaitoff, Angela C Weyand, Michael Fralick, Michelle Sholzberg

Blood (2023) 142 (Supplement 1): 1084.

https://doi.org/10.1182/blood-2023-174774

Published: 2023

Journal Articles

Evaluating Hemoglobin Thresholds on the Basis of Sex: Preliminary Insights from a Systematic Review

Ingrid Blydt-Hansen, Vidushi Swarup, Teruko Kishibe, Carine Bekdache, Mark A. Crowther, Angela C Weyand, Grace Tang, Michelle Sholzberg

Blood (2023) 142 (Supplement 1): 7200.

https://doi.org/10.1182/blood-2023-190173

Published: 2023

Journal Articles

Hemophilia A Research Program (HARP): A Novel Study Design for a Multicenter and Decentralized Prospective Observational Longitudinal Cohort Study in Hemophilia A

Jill M Johnsen, Shannon L Meeks, Grier P Page, Bhavya S Doshi, Marian T Sullivan, Mary-Anne Ardini, Angela C Weyand, Lynn Malec

Blood (2023) 142 (Supplement 1): 5494.

https://doi.org/10.1182/blood-2023-191010

Published: 2023

Journal Articles

Real-World Use of Recombinant Von Willebrand Factor in People with Clinically Severe Congenital Von Willebrand Disease: Interim Analysis of Athn 9: A Natural History Study for People with Severe VWD

Robert F. Sidonio, Angela C Weyand, Tammuella Chrisentery-Singleton, Martin Chandler, Haduwa Momoh, Priscilla Driscoll-Shempp, Bethany Jones, Natalia Nieto, Jorge Caicedo

Blood (2023) 142 (Supplement 1): 2613.

https://doi.org/10.1182/blood-2023-174729

Published: 2023

Journal Articles

Facilitators and Barriers to Accessing Antifibrinolytic and Iron Therapies for Patients Who Menstruate - a Global Healthcare Provider Survey

Carine Bekdache, Heather Vandermeulen, Grace Tang, Angela C Weyand, Michelle Sholzberg

Blood (2023) 142 (Supplement 1): 5071.

https://doi.org/10.1182/blood-2023-190501

Published: 2023

Journal Articles

Characteristics and Healthcare Utilization of Patients with Mild or Moderate Hemophilia A in the US - an Analysis from the Picnichealth Cohort

Anjali Sharathkumar, Yanrong Jiang, Hwai Jing Hiew, Athanasios Siadimas, Francis Nissen, Gillian Hanson, Emily Cibelli, Katya Moreno, Johnny Wharton, Angela C. Weyand

Blood (2022) 140 (Supplement 1): 2762–2763.

https://doi.org/10.1182/blood-2022-157712

Published: 2022

Journal Articles

Quality of Life in Patients with Clinically Severe Von Willebrand Disease: Interim Analysis of Athn 9: A Natural History Study for People with Severe Von Willebrand Disease (VWD)

Angela C. Weyand, Martin Chandler, Carol Fedor, Michael Recht, Robert F. Sidonio, Jr.

Blood (2022) 140 (Supplement 1): 5600–5602.

https://doi.org/10.1182/blood-2022-163302

Published: 2022

Journal Articles

Efficacy of Efanesoctocog Alfa on Physical Functioning: Results from the XTEND-1 Phase 3 Clinical Trial in Previously Treated Patients with Hemophilia A

Amanda Wilson, Nana Kragh, Jennifer Dumont, Jerome Mshijid, Annemieke Willemze, Linda Bystricka, Chuanwu Zhang, Angela C. Weyand, Kathelijn Fischer, Victor Jimenez-Yuste

Blood (2022) 140 (Supplement 1): 5595–5596.

https://doi.org/10.1182/blood-2022-167542

Published: 2022

Journal Articles

Characteristics and Bleeding Behavior of Females with Mild Hemophilia A: Longitudinal Study from Picnichealth Hemophilia A Database

Angela C. Weyand, Hwai Jing Hiew, Yanrong Jiang, Athanasios Siadimas, Francis Nissen, Gillian Hanson, Emily Cibelli, Katya Moreno, Hanlu Zhang, Anjali Sharathkumar

Blood (2022) 140 (Supplement 1): 61–62.

https://doi.org/10.1182/blood-2022-157727

Published: 2022

Journal Articles

Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome Associated with Enoxaparin Therapy in a Pediatric Patient

Aarti Kamat, Mary McGrath, Angela C. Weyand

Blood (2021) 138 (Supplement 1): 4269.

https://doi.org/10.1182/blood-2021-145763

Published: 2021

Journal Articles

Bleeding in Patients with Clinically Severe Von Willebrand Disease: Interim Analysis of Athn 9: A Natural History Study for People with Severe Von Willebrand Disease (VWD)

Angela C. Weyand, Martin Chandler, Carol Fedor, Kenneth D. Friedman, Sweta Gupta, Kristina M. Haley, Chunla He, Nikki Hirsh, Salley Pels, Jonathan C. Roberts, Tung T. Wynn, Robert F. Sidonio, Jr.

Blood (2021) 138 (Supplement 1): 3183.

https://doi.org/10.1182/blood-2021-145631

Published: 2021

NARROW

The Fuvid Study: Functional Characterization of Children with Pulmonary Embolism in a Prospective Multicenter Cohort Study

Real-World Patterns of Additional Factor Treatment Use Among Hemophilia a Patients on Regular Prophylaxis in the United States: Results from the Picnichealth Database

Changing the Serum Ferritin Lower Limit of Normal to a Clinical Decision Limit: An Acceptability Survey

Diagnosis and Disease Burden of Von Willebrand Disease in a Large US Population Based-Dataset

Disparities in Real-World Treatment Patterns Among Patients with Von Willebrand Disease in a Large US Population-Based Dataset

Analysis of the Hematology Health Equity Literature: Trends By Topic and Disparity, across Journals, and over Time

Continuous Prophylaxis with Recombinant Von Willebrand Factor in People with Clinically Severe Congenital Types 1 and 2 Von Willebrand Disease in a Real-World Setting: Interim Analysis of Athn 9, a Natural History Study for People with Severe VWD

Clinical Outcomes over 3 Years of Once-Weekly Efanesoctocog Alfa Treatment in Adults and Adolescents with Severe Hemophilia A: Second Interim Analysis from the Phase 3 XTEND-ed Long-Term Extension Study

Evaluation of Heavy Menstrual Bleeding in Adolescents within the Primary Care Setting

Evaluating Sex-Based Hemoglobin Reference Intervals Using Strict Definitions of Health

Evaluating Hemoglobin Thresholds on the Basis of Sex: Preliminary Insights from a Systematic Review

Hemophilia A Research Program (HARP): A Novel Study Design for a Multicenter and Decentralized Prospective Observational Longitudinal Cohort Study in Hemophilia A

Real-World Use of Recombinant Von Willebrand Factor in People with Clinically Severe Congenital Von Willebrand Disease: Interim Analysis of Athn 9: A Natural History Study for People with Severe VWD

Facilitators and Barriers to Accessing Antifibrinolytic and Iron Therapies for Patients Who Menstruate - a Global Healthcare Provider Survey

Characteristics and Healthcare Utilization of Patients with Mild or Moderate Hemophilia A in the US - an Analysis from the Picnichealth Cohort

Quality of Life in Patients with Clinically Severe Von Willebrand Disease: Interim Analysis of Athn 9: A Natural History Study for People with Severe Von Willebrand Disease (VWD)

Efficacy of Efanesoctocog Alfa on Physical Functioning: Results from the XTEND-1 Phase 3 Clinical Trial in Previously Treated Patients with Hemophilia A

Characteristics and Bleeding Behavior of Females with Mild Hemophilia A: Longitudinal Study from Picnichealth Hemophilia A Database

Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome Associated with Enoxaparin Therapy in a Pediatric Patient

Bleeding in Patients with Clinically Severe Von Willebrand Disease: Interim Analysis of Athn 9: A Natural History Study for People with Severe Von Willebrand Disease (VWD)

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only